ARCHIVES

NIH-funded HapMap consortium publishes first phase of catalog.

This article is from The Cancer Letter archive.

Vol. 31 No. 39 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Panel Explores Barriers In Access To Cancer Care.

February 2, 2001

FDA Expands Nexavar Indication To Include Thyroid Cancer

December 27, 2013

More Shakeups Coming Cooperative groups; Chairmen Consider Mutimembership Problems

February 20, 1976

Gene Expression Test Accurately Classifies “Inconclusive” Samples

July 27, 2012

Breast Implants Lessen Ability Of Mammograms To Find Cancer

February 27, 2004

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004